At a glance
ClinicalIndex Comparison RecordN/ACompleted· 223 enrolled
Drug / intervention
Naproxen +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Phase 3. Efficacy of Flavocoxid Compared With Naproxen in Subjects With Moderate-severe Osteoarthritis (OA) of the Knee
In Brief
A clinical study evaluating flavocoxid and Naproxen for Osteoarthritis of Knee. Completed, enrolled 223 participants.
Detailed Summary
To compare flavocoxid with naproxen for patients with moderate to severe osteoarthritis of the knee.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsOsteoarthritis of Knee
Countries--
Collaborators--
Timeline
N/ACompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartJan 2008
Primary CompletionAug 2008
First PostedNov 2008
TodayJul 2026
First PostedNov 14, 2008
Enrollment StartJan 1, 2008
Primary CompletionAug 1, 2008
TodayJul 2, 2026
Enrollment to primary: 7 monthsPosted 17.6 years ago
Interventions
flavocoxiddietary
medical food
Naproxendrug
antiinflammatory drug